Over $14M Bet On Diversified Healthcare Trust? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
Portfolio Pulse from Lisa Levin
Insiders have recently made significant purchases in three penny stocks: Diversified Healthcare Trust (DHC), Star Equity Holdings (STRR), and Adverum Biotechnologies (ADVM). DHC posted better-than-expected quarterly sales, Star Equity reported a profit for Q1, and Adverum introduced a gene therapy program for geographic atrophy.

June 12, 2023 | 1:25 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Adverum Biotechnologies' CFO Linda Rubinstein acquired 100,000 shares at an average price of $1.45, costing around $145.49 thousand. The company introduced a gene therapy program for geographic atrophy.
The insider purchase by the CFO indicates confidence in the company's prospects. The introduction of a gene therapy program for geographic atrophy suggests potential growth in the company's product pipeline, which may lead to a short-term increase in stock price.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
DHC director Adam Portnoy acquired 5,995,200 shares at an average price of $2.45, costing around $14.72 million. The company posted better-than-expected quarterly sales.
The significant insider purchase by the director indicates confidence in the company's prospects. The better-than-expected quarterly sales also suggest a positive outlook for the company, which may lead to a short-term increase in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Star Equity's Executive Chairman Jeffrey Eberwein acquired 102,000 shares at an average price of $1.09, spending around $111.46 thousand. The company posted a profit for Q1.
The insider purchase by the Executive Chairman shows confidence in the company's performance. The reported profit for Q1 also indicates a positive outlook for the company, which may lead to a short-term increase in stock price.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100